Diabetes complications

Current situation and progress of diabetic foot care in the Middle East and North Africa region

Diabetes Res Clin PractPublished Literature review and expert questionnaire survey

Authors' conclusion

The MENA region has the highest prevalence of diabetes among all international diabetes federation (IDF) regions. Research and publications are increasing with time. The standard diabetic foot management is in practice. New treatment modalities are launched, more or less rapidly, depending on multiple factors. The "diabetic foot" must be recognized as a disease entity. National registries for diabetic foot and amputations must be established. Health organizations and NGOs have a role to play in this region where citizens are undergoing amputations for financial reasons.

Study context

Population
Diabetic foot care in countries of the Middle East and North Africa (MENA) region
Outcome
Status of diabetic foot care in MENA
Methodological detailsMedical Subject Headings (MeSH) and free-text literature search, 14-question expert questionnaire, one per MENA country
  • MeSH and free-text literature search
  • 14-question expert questionnaire, one per MENA country

Main finding

As reported in the abstract

  • Number of publications low but increasing with time
  • National registries missing in most countries
  • Amputation rates moderate to high
  • Wide diversity among countries
  • Wound care, revascularization and flaps/grafts are mainstay of care in all countries
  • Advanced modalities more frequently used in Middle East than North Africa
  • Political stability, governmental vision and individual income affect level of foot care

Observational data: associations, not effects.

Original publication

Current situation and progress of diabetic foot care in the Middle East and North Africa region. Diabetes Res Clin Pract. Published 6 June 2025. doi:10.1016/j.diabres.2025.112318

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.